BBSRC Portfolio Analyser will be decommissioned at the end of 2025.
Other UKRI reporting services are available to you providing details of BBSRC investments: UKRI - What we have funded

Investigator / Supervisor details

NameDr Peter McLean
Current InstitutionGlaxoSmithKline plc
Current DepartmentHarlow
Previous Institutions

Current Awards

No current BBSRC awards

Completed Awards

ReferenceTitleAward RoleValue £Type
02/A4/S/08637 Enteroendocrine cell hyperplasia and visceral sensation Co-Supervisor 59,287 Studentships
terms and conditions of use (opens in new window)
export PDF file